Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Tamoxifen|DRUG: Exemestane
Sponsor: Pfizer
Collaborators: International Collaborative Cancer Group